Congenital heart disease (CHD) represents one of the most important health challenges, affecting approximately from 3% to 10% of live births (Bouma & Mulder, 2017) and representing 0.8%-1.2% of all congenital birth defects (Marelli et al., 2007). The life expectancy of patients with CHD has deeply changed over the past decades, thanks to the progress in diagnosis, the refinement of percutaneous and surgical interventions and devices, the discovery of biomarkers and clinical research (Bouma & Mulder, 2017;Engelfriet et al., 2005).More than 85% of CHD children currently reach adulthood (Giamberti et al., 2016). Accordingly, a transition from childhood to adulthood has become a reality for most patients (Flocco et al., 2018(Flocco et al., , 2019, resulting in a new CHD adult population (Dellafiore et al., 2019).Currently, the percentage of CHD women who are becoming pregnant is increasing worldwide (Opotowsky et al., 2012), and pregnancy and motherhood constitute a challenge for these women due to the high risk of complications associated with the complexity of